[HTML][HTML] Filgrastim therapy in a child with neutropenia induced by linezolid

M Hernández Segurado, MÁ Arias Moya… - International Journal of …, 2013 - Springer
We describe the case of a young child with multidrug-resistant tuberculosis, treated with
linezolid. The child developed severe neutropenia after 5 months of treatment. Filgrastim …

4CPS-028 Effectiveness and safety of cenobamate: experience in a third-level hospital

B Ardizone, FJB Martínez, MH Segurado, ET Esteban… - 2022 - ejhp.bmj.com
Background and importance More than one-third of patients with epilepsy have uncontrolled
seizures despite being treated with two or more anti-seizure medications (ASM); this …

PS-033 Preventing medicines errors by medicines reconciliation at admission and discharge

MH Segurado, FJB Martínez, MB Porras, MÁA Moya… - 2015 - ejhp.bmj.com
Background Institutions related to healthcare quality, such as the Joint Commission,
recognise that reconciliation errors (REs) compromise the safe use of medicines. Purpose …

OHP-007 Prescription of oral supplements during a hospitalisation period

MF Perez-Minayo, PP Torres, LG Jimenez… - 2017 - ejhp.bmj.com
Background The early diagnosis of malnutrition brings clinical and economic benefits in
hospitalised patients, especially in the elderly. However, the prevalence of malnutrition …

DGI-064 Study of the Use of Ferric Carboxymaltose (FC) Within the System For Preoperative Optimization of Haemoglobin (Hb) in Scheduled Surgery

MG Pérez, MAA Moya, MH Segurado… - European Journal of …, 2013 - ejhp.bmj.com
Background In our hospital there is a protocol for preoperative Hb optimization with the aim
of reducing blood transfusions in patients with anaemia and upcoming surgery. Purpose To …

CPC-045 Efficacy and Safety of Boceprevir and Telaprevir at Week 12 of Treatment

MG Perez, MB Porras, BR Vargas… - European Journal of …, 2013 - ejhp.bmj.com
Background Boceprevir and telaprevir are two new drugs approved by the European
Medicines Agency for the treatment of hepatitis C genotype 1. They are used in combination …

PS-107 Review of absence or presence of lactose in oral cytostatic drugs

MAA Moya, EMM Gozalo, PP Torres, MF Pérez-Minayo… - 2015 - ejhp.bmj.com
Background In humans, lactase activity continues after weaning and in adulthood in about
30% of the population (lactase persistence), but in the others the lactase enzyme is absent …

4CPS-001 Comparative analysis of two pharmacokinetic programs for lithium adjustment

ABP Fonseca, NB Ruíz, ÁLS Mingoarranz… - 2024 - ejhp.bmj.com
Background and Importance Therapeutic drug monitoring (TDM) is the clinical practice of
measuring drugs to maintain a constant concentration in the patient's blood, thereby …

DI-027 Pemetrexed use in patients with stage IV lung adenocarcinoma who undergo thymidylate synthase level investigation

MF Pérez-Minayo, EC Bazán, FJB Martínez, MB Porras… - 2015 - ejhp.bmj.com
Background Determination of thymidylate synthase (TS) levels in tumour tissue versus
control tissue is useful in our hospital when selecting patients who can benefit from …

CP-077 Evaluation of glutamine supplementation in parenteral nutrition in a general hospital

MH Segurado, MIP Esteban, BR Vargas… - European Journal of …, 2014 - ejhp.bmj.com
Background The administration of glutamine (GLU) intravenously as part of protein intake in
patients who are given parenteral nutrition (PN) is associated with fewer infectious …